Content
63%Weight 40%Scale 1-5Reviews the quality of instructions and guidance provided to agents. Good implementation is clear, handles edge cases, and produces reliable results.
A well-structured, actionable workflow guide with clear phase sequencing and concrete tool documentation. Weaker on conciseness (concept re-explanation) and progressive disclosure (monolithic inline content with no reference files).
Suggestions
Trim the 'Reasoning Strategy' paragraph to remove background immunology Claude already knows (e.g. the HLA-B27/ankylosing spondylitis and abacavir examples), keeping only the operational 'LOOK UP DON'T GUESS' directive.
Add at least one executable Python snippet under 'COMPUTE, DON'T DESCRIBE' so the compute guidance is copy-paste ready rather than directive-only.
Extract the per-phase tool schemas and binding-affinity/drug-association tables into reference files under ./references/ and link them from SKILL.md to establish a one-level-deep overview-to-detail structure.
| Dimension | Reasoning | Score |
|---|---|---|
Conciseness | Mostly operational, but the 'Reasoning Strategy' section explains immunology concepts Claude already knows (peptide presentation, HLA-B27/ankylosing spondylitis, abacavir hypersensitivity) that could be trimmed. | 3 / 5 |
Actionability | Concrete tool names with input/output schemas, specific binding-affinity thresholds, and numbered workflows; minor gap is the 'COMPUTE, DON'T DESCRIBE' directive giving no executable code example. | 4 / 5 |
Workflow Clarity | Seven phases are clearly sequenced with an ASCII diagram and per-phase Objective/Tools/Workflow; validation is fallback-style rather than explicit checkpoints, but the skill is non-destructive so no cap applies. | 4 / 5 |
Progressive Disclosure | No bundle files exist and the ~230-line body inlines full tool schemas and per-phase detail that could be split into references; sections are well-organized but there is no overview-to-reference layering. | 3 / 5 |
Total | 14 / 20 Passed |